T Eguale, DL Buckeridge, NE Winslade… - Archives of Internal …, 2012 - europepmc.org
Background Off-label prescribing may lead to adverse drug events. Little is known about its prevalence and determinants resulting from challenges in documenting treatment indication …
T Eguale, DL Buckeridge, NE Winslade, A Benedetti… - 2012 - escholarship.mcgill.ca
Background Off-label prescribing may lead to adverse drug events. Little is known about its prevalence and determinants resulting from challenges in documenting treatment indication …
A Benedetti, JA Hanley, R Tamblyn - Arch Intern Med, 2012 - scholar.archive.org
Background: Off-label prescribing may lead to adverse drug events. Little is known about its prevalence and determinants resulting from challenges in documenting treatment indication …
A Benedetti, JA Hanley, R Tamblyn - Arch Intern Med, 2012 - researchgate.net
Background: Off-label prescribing may lead to adverse drug events. Little is known about its prevalence and determinants resulting from challenges in documenting treatment indication …
T EGUALE, DL BUCKERIDGE… - Archives of internal …, 2012 - pascal-francis.inist.fr
Drug, Patient, and Physician Characteristics Associated With Off-label Prescribing in Primary Care CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
T Eguale, DL Buckeridge… - Archives of internal …, 2012 - pubmed.ncbi.nlm.nih.gov
Background Off-label prescribing may lead to adverse drug events. Little is known about its prevalence and determinants resulting from challenges in documenting treatment indication …